Show simple item record

Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders

dc.contributor.authorHendriksz, Christian J.pt_BR
dc.contributor.authorHarmatz, Paulpt_BR
dc.contributor.authorGiugliani, Robertopt_BR
dc.contributor.authorRoberts, Jane T.pt_BR
dc.contributor.authorArul, G. Surenpt_BR
dc.date.accessioned2019-06-22T02:35:04Zpt_BR
dc.date.issued2017pt_BR
dc.identifier.issn2214-4269pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/196097pt_BR
dc.description.abstractTotally implantable vascular access devices (TIVADs) are commonly used in conjunction with enzyme replacement therapy (ERT) for lysosomal storage disorders (LSDs). This case series describes potential complications associated with long-term TIVAD use, such as compromise of skin integrity, infection, or port failures. Best practices and skilled specialists are essential for minimizing complications from long-term TIVAD use for ERT.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofMolecular genetics and metabolism reports. Amsterdam. vol. 15 (June 2018), p. 71-73.pt_BR
dc.rightsOpen Accessen
dc.subjectMucopolysaccharidosisen
dc.subjectMucopolissacaridosespt_BR
dc.subjectEnzyme replacement therapyen
dc.subjectTerapia de reposição de enzimaspt_BR
dc.subjectDispositivos de acesso vascularpt_BR
dc.subjectTotally implantable venous access deviceen
dc.subjectDoenças por armazenamento dos lisossomospt_BR
dc.subjectLysosomal storage disorderen
dc.titleRisks of long-term port use in enzyme replacement therapy for lysosomal storage disorderspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001089838pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
Name:
001089838.pdf
Size:
143.5Kb
Format:
PDF
Description:
Texto completo (inglês)
View/Open
   

This item is licensed under a Creative Commons License

Show simple item record